Review
Open access
Sep 2026
Beyond Tacrolimus: Towards Personalized Immunosuppression in Heart Transplantation
Heart transplantation remains the definitive treatment for end-stage heart failure and contemporary immunosuppressive regimens, typically a calcineurin inhibitor, antiproliferative agent, and corticosteroids, are applied with minimal pre-emptive individualization, despite profound heterogeneity in recipient immune biol...
Marc D. Samsky, Maryjane Farr, Aditya Parikh et al.
· Journal of Cardiac Failure · 0 citations